Meta-analysis of the efficacy of escitalopram and citalopram in the treatment of major depressive disorder.

被引：0
|
作者：
Kasper, S
Auquier, P
Robitail, S
Llorca, PM
Rive, B
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Fac Med, Marseille, France
[3] Ctr Hosp Univ, Clermont Ferrand, France
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2005年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [1] Escitalopram in the treatment of major depressive disorder: A meta-analysis
    Kennedy, Sidney H.
    Andersen, Henning F.
    Thase, Michael E.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 161 - 175
  • [2] Escitalopram and citalopram in the treatment of major depressive disorder
    Andersen, HF
    Lam, RW
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 404 - 405
  • [3] Escitalopram and citalopram in the treatment of outpatients with major depressive disorder
    Moore, N
    Verdoux, H
    Fantino, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S426 - S426
  • [4] The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: An extended analysis
    Lam, R. W.
    Andersen, H. F.
    [J]. PHARMACOPSYCHIATRY, 2006, 39 (05) : 180 - 184
  • [5] The efficacy of citalopram or escitalopram in patients with asthma and major depressive disorder
    Agarwal, Catherine D.
    Palka, Jayme M.
    Gajewski, Alexander J.
    Khan, David A.
    Brown, Sherwood
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 374 - 382
  • [6] Efficacy and Safety of Escitalopram in the Treatment of Major Depressive Disorder in Chinese Patients: A Meta-Analysis Study
    Gou, Mingyang
    [J]. 2019 ASIA-PACIFIC CONFERENCE ON CLINICAL MEDICINE AND PUBLIC HEALTH (CMPH 2019), 2019, : 83 - 88
  • [7] METABOLOMIC SIGNATURES OF DRUG RESPONSE PHENOTYPES FOR CITALOPRAM AND ESCITALOPRAM IN SUBJECTS WITH MAJOR DEPRESSIVE DISORDER.
    Mahmoudiandehkordi, S.
    Bhattacharyya, S.
    Liu, D.
    Ahmed, A.
    Arnold, M.
    Luo, C.
    Zhu, H.
    Neavin, D.
    Athreya, A.
    Louie, G.
    Dunlop, B.
    Frye, M.
    Wang, L.
    Weinshilboum, R.
    Krishnan, R.
    Rush, A. J.
    Kaddurah-Daouk, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S105 - S105
  • [8] METABOLOMIC SIGNATURES OF DRUG RESPONSE PHENOTYPES FOR CITALOPRAM AND ESCITALOPRAM IN SUBJECTS WITH MAJOR DEPRESSIVE DISORDER.
    Mahmoudiandehkordi, S.
    Bhattacharyya, S.
    Liu, D.
    Ahmed, A.
    Arnold, M.
    Luo, C.
    Zhu, H.
    Neavin, D.
    Athreya, A.
    Louie, G.
    Dunlop, B.
    Frye, M.
    Wang, L.
    Weinshilboum, R.
    Krishnan, R.
    Rush, A. J.
    Kaddurah-Daouk, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S10 - S10
  • [9] Efficacy of escitalopram compared to citalopram: a meta-analysis
    Montgomery, Stuart
    Hansen, Thomas
    Kasper, Siegfried
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (02): : 261 - 268
  • [10] Comparison of escitalopram and citalopram efficacy: A meta-analysis
    Auquier, P
    Robitail, S
    Llorca, PM
    Rive, B
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (04) : 259 - 268
12345